Page last updated: 2024-11-02

pifithrin and Carotid Artery Diseases

pifithrin has been researched along with Carotid Artery Diseases in 1 studies

pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source

Carotid Artery Diseases: Pathological conditions involving the CAROTID ARTERIES, including the common, internal, and external carotid arteries. ATHEROSCLEROSIS and TRAUMA are relatively frequent causes of carotid artery pathology.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leeper, NJ1
Raiesdana, A1
Kojima, Y1
Kundu, RK1
Cheng, H1
Maegdefessel, L1
Toh, R1
Ahn, GO1
Ali, ZA1
Anderson, DR1
Miller, CL1
Roberts, SC1
Spin, JM1
de Almeida, PE1
Wu, JC1
Xu, B1
Cheng, K1
Quertermous, M1
Kundu, S1
Kortekaas, KE1
Berzin, E1
Downing, KP1
Dalman, RL1
Tsao, PS1
Schadt, EE1
Owens, GK1
Quertermous, T1

Other Studies

1 other study available for pifithrin and Carotid Artery Diseases

ArticleYear
Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation.
    Arteriosclerosis, thrombosis, and vascular biology, 2013, Volume: 33, Issue:1

    Topics: Adolescent; Adult; Aged; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apoptosis; Benzothia

2013